CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rosetta Genomics Ltd (USA) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rosetta Genomics Ltd (USA)
10 Plaut Street, Science Park, Pob 4059
Phone: +972 732220700p:+972 732220700 REHOVOT, 76706  Israel Ticker: ROSG ROSG
Filed for Bankruptcy on 5/31/2018
On 5/31/2018, Rosetta Genomics Ltd. filed for Bankruptcy in Israel.
Business Summary
Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests-based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH). The Company is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY and RosettaGX Reveal. The Company's therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. The Company focuses on developing diagnostic assay, RosettaGX Reveal V2. It is also focusing on developing Bladder cancer risk stratification.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201712/31/2016YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Brian A.Markison 63 4/12/2011 3/1/2011
Chief Financial Officer RonKalfus 41 5/1/2012 5/1/2012
Senior Director Of Finance SigalRusso-Gueta 38
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Rosetta Genomics, Inc. 3711 Market Street Philadelphia PA United States

Business Names
Business Name
Minuet Diagnostics, Inc.
Rosetta Genomics Inc.
ROSG
ROSGF
ROSGQ

General Information
Number of Employees: 86 (As of 12/31/2016)
Outstanding Shares: 5,929,860 (As of 3/12/2018)
Stock Exchange: OTC
Fax Number: +972 732220701


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023